Cannabis sales in February 2026 (BDSA data)
Cannabis sales in February 2026 (BDSA data) reveal a complex market shift worth close attention. Across 15 major markets, total retail receipts hit 1.99 billion dollars in February. However, sequential sales fell 3.6 percent even as per-day sales rose 6.7 percent. Because February had fewer selling days, analysts look at per-day figures for clarity. This article will unpack monthly cannabis sales and the drivers behind the numbers. We will examine regional trends, adult-use rollouts, and medical-only market impacts.
Ohio stands out with strong year-over-year growth, while Missouri showed weakness. Meanwhile, states like Florida and Pennsylvania remain shaped by medical-only dynamics. Therefore, investors and operators need a data-driven view to plan ahead. Read on for a detailed dive into BDSA data, state-level patterns, and implications. The goal is clear: translate numbers into actionable insight for the coming quarters. We also highlight competitive pressure and pricing trends that moved sales. As a result, readers will leave with clear takeaways and next steps.
Cannabis sales in February 2026 (BDSA data) — Sales insights
BDSA shows a mixed performance across 15 tracked markets in February. Total retail receipts reached $1.99 billion, but sequential sales fell 3.6 percent. However, because February had fewer selling days, per-day sales rose 6.7 percent. Therefore, per-day metrics give a clearer view of consumer activity. Analysts should watch both headline and adjusted numbers.
Key February figures and trends
- Total across 15 markets: $1.99 billion.
- Sequential change: -3.6 percent.
- Per-day sequential change: +6.7 percent.
- Year-over-year range: -1.5 percent (Missouri) to +27.3 percent (Ohio).
- Ohio growth reflects adult-use rollout beginning in August 2025.
Regional dynamics mattered in February. Western markets showed soft sequential demand. Meanwhile, eastern markets varied because some remain medical-only. For example, Florida and Pennsylvania still operate medical-only programs. As a result, pricing and product mixes differ across states.
Competitive pressure and market maturation influenced outcomes. New store openings and promotional activity compressed price points, therefore cutting headline sales. Moreover, two markets reported negative annual growth. Consequently, only one state posted clear sequential improvement.
For deeper context, consult the original BDSA report at BDSA and related analysis at New Cannabis Ventures. These sources offer state-level breakdowns and methodology notes. In summary, February shows cautious demand. Going forward, operators should track per-day sales and state-specific policy changes.
Evidence and detailed data: Cannabis sales in February 2026 (BDSA data)
BDSA provides clear metrics for February across 15 tracked markets. Total retail receipts reached $1.99 billion. However, headline sales fell sequentially by 3.6 percent. When adjusted for fewer selling days, per-day sales rose 6.7 percent. Therefore, analysts should consider both headline and per-day figures to avoid misleading conclusions.
Key state and market evidence
| Category | Metric or figure | Note |
|---|---|---|
| Scope | 15 tracked markets | BDSA coverage for the report |
| Total sales | $1.99 billion | February 2026 across tracked markets |
| Sequential change | -3.6 percent | Month-over-month headline change |
| Per-day sequential change | +6.7 percent | Adjusted for fewer selling days in February |
| Ohio year-over-year | +27.3 percent | Boosted by adult-use launch in August 2025 |
| Missouri year-over-year | -1.5 percent | Among the weaker state performances |
| Medical-only examples | Florida and Pennsylvania | Product mix and pricing differ by program |
| Markets with negative annual growth | 2 markets | Indicates pockets of decline |
Interpretation and next steps
BDSA data show mixed momentum. Meanwhile, regional differences matter more than national averages. For full state breakdowns and methodology, see BDSA at BDSA and New Cannabis Ventures at New Cannabis Ventures. As a result, operators should track per-day sales, state policy shifts, and local competitive pressure.
Market implications and consumer behavior: Cannabis sales in February 2026 (BDSA data)
Cannabis sales in February 2026 (BDSA data) point to evolving consumer choices and strategic risks for operators. Total across 15 markets stood at 1.99 billion dollars. However, headline sales fell 3.6 percent sequentially. Therefore per-day sales rose 6.7 percent after adjusting for fewer selling days.
Key implications for market strategy and consumer behavior
- Shifts toward value and promotions. Because competition intensified, consumers responded to discounts and bundles. As a result, average transaction values slipped in some markets.
- Regional preference variance. Western markets showed soft sequential demand, meanwhile eastern markets differed because of medical-only programs in Florida and Pennsylvania.
- Product mix matters. Sales of flower remained steady, but demand grew faster for concentrates and edibles in adult-use rollouts, for example Ohio.
- Store footprint and convenience win. New openings increased local supply, therefore reducing trip frequency and lowering headline sales.
- Pricing pressure and margin erosion. Competitive price cuts drove volume but squeezed margins for retailers and producers.
- Policy and rollout effects. Ohio saw a 27.3 percent year over year gain after adult-use launch, therefore regulatory timing alters demand trajectories.
Operators should monitor per-day sales, product category shifts, and local competition closely. For full state breakdowns and methodology consult BDSA and New Cannabis Ventures. As a result, firms can adapt pricing, assortment, and loyalty programs for sustained growth.
Conclusion — Cannabis sales in February 2026 (BDSA data)
Cannabis sales in February 2026 (BDSA data) show mixed momentum across 15 tracked markets. Total retail receipts hit $1.99 billion, yet headline sales fell 3.6 percent month over month. However, per-day sales rose 6.7 percent after adjusting for fewer selling days. Ohio delivered the strongest year over year gain at +27.3 percent. Meanwhile, Missouri and two other markets showed negative annual growth. Because regional dynamics and adult-use rollouts matter, operators must use state-level data. As a result, pricing, promotions, and store footprints will shape near-term performance.
We also highlight EMP0 as an emerging consideration for market watchers. Therefore, analysts should assess EMP0 alongside price and assortment metrics. In practice, firms should prioritize per-day trends, category shifts, and local competitive moves.
MyCBDAdvisor provides trustworthy, research driven insights for cannabinoid consumers and businesses. Visit MyCBDAdvisor for data summaries, expert commentary, and actionable recommendations. Finally, use BDSA data and local intelligence to align strategy with real demand.
Frequently Asked Questions — Cannabis sales in February 2026 (BDSA data)
What were the headline results for Cannabis sales in February 2026 (BDSA data)?
BDSA reports total retail sales of $1.99 billion across 15 markets in February 2026. Sequential sales fell 3.6 percent. However, per-day sales rose 6.7 percent after adjusting for fewer selling days. Therefore, per-day metrics show stronger underlying consumer activity.
Why did headline sales decline month over month?
February had fewer selling days, which lowered headline totals. Meanwhile, competitive promotions and new store openings compressed prices and transaction frequency. As a result, operators saw lower headline receipts even as consumer demand held steady on a per-day basis.
Which states and channels drove the biggest differences?
Ohio led with a 27.3 percent year-over-year gain after its adult-use rollout in August 2025. Missouri recorded a -1.5 percent year-over-year result and ranked among the weakest states. Florida and Pennsylvania remain medical-only, which influenced product mix and pricing. Retail channels saw stronger growth in concentrates and edibles in adult-use rollouts.
What are the practical implications for operators and consumers?
Operators should track per-day sales and category shifts closely. They must optimize pricing, loyalty programs, and local assortment to defend margin. Consumers will likely see more value promotions, therefore shopping patterns may shift toward deals and convenience.
Where can I access the full BDSA report and further analysis?
Find the BDSA report and methodology at BDSA. For market commentary and state-level breakdowns see New Cannabis Ventures. For research-driven guidance for consumers and businesses visit MyCBDAdvisor.
